Section Arrow
CORT.NASDAQ
- Corcept Therapeutics
Quotes are at least 15-min delayed:2025/06/03 04:25 EDT
Last
 71.68
-5.88 (-7.58%)
Day High 
86.2 
Prev. Close
77.56 
1-M High
80.645 
Volume 
6.06M 
Bid
69.8
Ask
80
Day Low
70 
Open
77.56 
1-M Low
67 
Market Cap 
8.22B 
Currency USD 
P/E 69.57 
%Yield -- 
10-SMA 76.64 
20-SMA 74.14 
50-SMA 71.51 
52-W High 117.33 
52-W Low 28.04 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.15/3.76
Enterprise Value
8.23B
Balance Sheet
Book Value Per Share
6.44
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
482.38M
Operating Revenue Per Share
4.24
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OGENOragenics0.166+0.046+38.33%-- 
PSTVPlus Therapeutics0.3677+0.0808+28.16%-- 
NCNANuCana plc0.038+0.0027+7.65%-- 
PCSAProcessa Pharmaceuticals0.298+0.0055+1.88%-- 
BPMCBlueprint Medicines Corp127.79+26.44+26.09%-- 
Quotes are at least 15-min delayed:2025/06/03 04:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.